These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 10936116

  • 21. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
    Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.
    Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P.
    Pneumonol Alergol Pol; 2013 Sep; 81(6):527-36. PubMed ID: 24142782
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW.
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [Abstract] [Full Text] [Related]

  • 24. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 25. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [Abstract] [Full Text] [Related]

  • 26. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun 29; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 28. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
    Pediatr Pulmonol; 2000 Aug 29; 30(2):97-105. PubMed ID: 10922131
    [Abstract] [Full Text] [Related]

  • 29. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 29; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug 29; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

  • 31. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug 29; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

  • 32. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct 29; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 33. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
    Nathan RA, Bleecker ER, Kalberg C, Fluticasone Propionate Study Group.
    Am J Med; 2001 Aug 15; 111(3):195-202. PubMed ID: 11530030
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr 15; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
    Pulm Pharmacol Ther; 2009 Jun 15; 22(3):214-20. PubMed ID: 19141327
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study.
    Wolfe JD, Selner JC, Mendelson LM, Hampel F, Schaberg A.
    Clin Ther; 1996 Jun 15; 18(4):635-46. PubMed ID: 8879892
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
    Thorax; 2001 Mar 15; 56(3):186-91. PubMed ID: 11182010
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
    Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Uffelen R, Kesten S, Jones AL.
    Respir Med; 1993 Nov 15; 87(8):609-20. PubMed ID: 8290745
    [Abstract] [Full Text] [Related]

  • 39. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
    Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T.
    Am J Respir Crit Care Med; 2000 Feb 15; 161(2 Pt 1):527-34. PubMed ID: 10673196
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov 15; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.